NCT04521686 2025-06-27Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT00620295 2017-11-29Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsMasonic Cancer Center, University of MinnesotaPhase 1 Completed17 enrolled
NCT00004095 2017-04-18Irinotecan Plus Gemcitabine in Treating Patients With Unresectable or Metastatic Solid TumorsNorthwestern UniversityPhase 1 Completed38 enrolled
NCT01325558 2016-07-15A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid TumorsAltor BioSciencePhase 1 Completed30 enrolled